Eosinophils cocultured with endothelial cells have increased survival and functional properties.

Human peripheral blood eosinophils, cells often associated with allergic and parasitic diseases, were maintained in vitro for at least 14 days when they were cocultured with bovine endothelial cells and for at least 7 days when cultured with either bovine or human endothelial cell-derived conditioned medium. The cocultured eosinophils became hypodense and generated about three times as much leukotriene C4 upon activation with calcium ionophore and killed about three times as many antibody-coated larvae of Schistosoma mansoni as freshly isolated normodense eosinophils. That these cells can be maintained in vitro by coculture with endothelial cells, and the surprising finding that the cocultured eosinophils have biochemical, cytotoxic, and density properties similar to those of eosinophils in patients with allergic and other disorders, will facilitate investigation of the regulation and role of these cells in health and disease.

[1]  A. Sheffer,et al.  Synthesis and release of leukotriene C4 by human eosinophils. , 1987, Journal of immunology.

[2]  A. Wardlaw,et al.  Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. , 1986, The Journal of clinical investigation.

[3]  J. Dipersio,et al.  Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.

[4]  J. Gamble,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. , 1986, The Journal of clinical investigation.

[5]  H. Koeffler,et al.  Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factor , 1986, Nature.

[6]  C. Begley,et al.  Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. , 1986, Blood.

[7]  K. Austen,et al.  Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. , 1985, Journal of immunology.

[8]  S. Orkin,et al.  Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis , 1985, Nature.

[9]  A. Capron,et al.  Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. , 1984, Clinical and experimental immunology.

[10]  W. Henderson,et al.  Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. , 1984, Immunology.

[11]  E. Levine,et al.  Human endothelial cells: use of heparin in cloning and long-term serial cultivation. , 1983, Science.

[12]  M. Vadas,et al.  Maturation In Vivo of Schistosoma mansoni Schistosomula After Culture In Vitro with Granulocytes and Antibody , 1983, Infection and immunity.

[13]  I. Olsson,et al.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia. , 1982, Immunology.

[14]  C. De Simone,et al.  Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities. , 1982, Clinical and experimental immunology.

[15]  S. Broder,et al.  Metabolic heterogeneity of eosinophils from normal and hypereosinophilic patients. , 1981, Blood.

[16]  T. Maciag,et al.  Serial propagation of human endothelial cells in vitro , 1981, The Journal of cell biology.

[17]  James R. Smith,et al.  Expression of angiotensin‐converting enzyme activity in cultured pulmonary artery endothelial cells , 1981, Journal of cellular physiology.

[18]  P. Quesenberry,et al.  Vascular endothelium as a regulator of granulopoiesis: production of colony-stimulating activity by cultured human endothelial cells. , 1980, Blood.

[19]  R. Ross,et al.  An endothelial cell-derived growth factor , 1980, The Journal of cell biology.

[20]  M. Vadas,et al.  A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. , 1979, Journal of immunology.

[21]  S. A. Cruise,et al.  Isolation and primary culture of endothelial cells from human umbilical vessels , 1978 .

[22]  A. Sher,et al.  Eosinophils as mediators of antibody-dependent damage to schistosomula , 1975, Nature.

[23]  H. Mita,et al.  Release of leukotriene C4 from human eosinophils and its relation to the cell density. , 1985, International archives of allergy and applied immunology.

[24]  A. Capron,et al.  Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. , 1983, International archives of allergy and applied immunology.